drugset / Trial / NCT00844090

The Role of Apathy in Glycemic Control

NCT00844090

Completed 106 enrolled US Department of Veterans Affairs
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In spite of several new medications and insulins for the control of blood sugars in patients with diabetes, a large number of patients do not have good control. This likely due to inability to carry out regular activities and self-care behaviors such as taking meds regularly, keeping a good diet, exercise etc. This inability to carry out self care lifestyle changes may be due to a condition called apathy. Apathy is a lack of motivation and persistence. In this study we will attempt to treat apathy with a medication called methylphenidate for 6 months and see if blood sugar/diabetes control improves.

Timeline

Start
2009-07
Primary completion
2012-08
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule

Indications